Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 15.95% is 11% below its 5-year average of 17.95%, around the middle of its 5-year range (9.35%–31.29%).
9.20% above its 12-month average of 14.61%.
Reported quarterly profit margin; no daily interpolation.
NET PROFIT MARGIN
15.95%
NET PROFIT MARGIN AVG TTM
14.61%
NET PROFIT MARGIN AVG 3Y
16.50%
NET PROFIT MARGIN AVG 5Y
17.95%
NET PROFIT MARGIN AVG 10Y
16.29%
NET PROFIT MARGIN AVG 15Y
14.85%
NET PROFIT MARGIN AVG 20Y
14.04%
CURRENT VS TTM AVG
+9.20%
CURRENT VS 3Y AVG
-3.31%
CURRENT VS 5Y AVG
-11.14%
CURRENT VS 10Y AVG
-2.06%
CURRENT VS 15Y AVG
+7.44%
CURRENT VS 20Y AVG
+13.57%
SECTOR MEDIAN · HEALTHCARE
8.98%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+77.62%
vs the sector median at left
Danaher Corporation
Market Cap
$144.25B
Net Profit Margin
15.95%
TTM Avg
14.61%
3Y Avg
16.50%
5Y Avg
17.95%
Market Cap
$134.24B
Net Profit Margin
34.89%
TTM Avg
13.94%
3Y Avg
25.44%
5Y Avg
29.40%
Market Cap
$132.14B
Net Profit Margin
18.87%
TTM Avg
-1.95%
3Y Avg
6.91%
5Y Avg
3.60%
Market Cap
$123.70B
Net Profit Margin
28.45%
TTM Avg
28.09%
3Y Avg
25.67%
5Y Avg
26.14%
Market Cap
$118.26B
Net Profit Margin
13.93%
TTM Avg
13.55%
3Y Avg
12.62%
5Y Avg
13.06%
Market Cap
$182.06B
Net Profit Margin
-10.64%
TTM Avg
15.29%
3Y Avg
17.07%
5Y Avg
15.27%
Market Cap
$105.97B
Net Profit Margin
14.43%
TTM Avg
13.09%
3Y Avg
13.60%
5Y Avg
12.87%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Danaher Corporation (DHR) | $144.25B | 15.95% | 14.61% | 16.50% | 17.95% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $134.24B | 34.89% | 13.94% | 25.44% | 29.40% |
| Bristol-Myers Squibb Company (BMY)vs › | $132.14B | 18.87% | -1.95% | 6.91% | 3.60% |
| Pfizer Inc. (PFE)vs › | $158.39B | 6.81% | 12.51% | 14.97% | 18.18% |
| Intuitive Surgical, Inc. (ISRG)vs › | $123.70B | 28.45% | 28.09% | 25.67% | 26.14% |
| CVS Health Corp. (CVS)vs › | $122.58B | 1.18% | 0.84% | 1.34% | 1.79% |
| Medtronic plc (MDT)vs › | $118.26B | 13.93% | 13.55% | 12.62% | 13.06% |
| Gilead Sciences, Inc. (GILD)vs › | $182.06B | -10.64% | 15.29% | 17.07% | 15.27% |
| Stryker Corporation (SYK)vs › | $105.97B | 14.43% | 13.09% | 13.60% | 12.87% |
| Abbott Laboratories (ABT)vs › | $182.59B | 11.65% | 23.34% | 19.20% | 17.71% |
Operating Margin
20.4%
Net Profit Margin
15.9%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-26 | 13.89% |
| 2026-03-27 | 17.29% |
| 2025-12-31 | 17.51% |
| 2025-09-26 | 15.00% |
| 2025-06-27 | 9.35% |
| 2025-03-28 | 16.62% |
| 2024-12-31 | 16.61% |
| 2024-09-27 | 14.11% |
| 2024-06-28 | 15.79% |
| 2024-03-29 | 18.77% |
| 2023-12-31 | 16.85% |
| 2023-09-29 | 20.07% |
| 2023-06-30 | 15.45% |
| 2023-03-31 | 24.37% |
| 2022-12-31 | 31.29% |
| 2022-09-30 | 20.51% |
| 2022-07-01 | 21.67% |
| 2022-04-01 | 22.44% |
| 2021-12-31 | 21.94% |
| 2021-10-01 | 16.02% |
| 2021-07-02 | 24.73% |
| 2021-04-02 | 24.82% |
| 2020-12-31 | 18.36% |
| 2020-10-02 | 15.02% |
| 2020-07-03 | 17.50% |
| 2020-04-03 | 13.70% |
| 2019-12-31 | 16.93% |
| 2019-09-27 | 15.26% |
| 2019-06-28 | 16.45% |
| 2019-03-29 | 7.91% |
| 2018-12-31 | 16.22% |
| 2018-09-28 | 13.68% |
| 2018-06-29 | 13.53% |
| 2018-03-30 | 12.07% |
| 2017-12-31 | 16.84% |
| 2017-09-29 | 12.63% |
| 2017-06-30 | 12.36% |
| 2017-03-31 | 12.03% |
| 2016-12-31 | 16.29% |
| 2016-09-30 | 9.48% |
| 2016-07-01 | 11.35% |
| 2016-04-01 | 14.08% |
| 2015-12-31 | 11.70% |
| 2015-10-02 | 27.94% |
| 2015-07-03 | 13.57% |
| 2015-04-03 | 11.69% |
| 2014-12-31 | 12.21% |
| 2014-09-26 | 13.97% |
| 2014-06-27 | 13.63% |
| 2014-03-28 | 12.43% |
| 2013-12-31 | 14.99% |
| 2013-09-27 | 12.79% |
| 2013-06-28 | 13.02% |
| 2013-03-29 | 15.57% |
| 2012-12-31 | 12.67% |
| 2012-09-28 | 12.43% |
| 2012-06-29 | 13.18% |
| 2012-03-30 | 14.20% |
| 2011-12-31 | 12.64% |
| 2011-09-30 | 11.59% |
| 2011-07-01 | 17.48% |
| 2011-04-01 | 12.83% |
| 2010-12-31 | 13.13% |
| 2010-10-01 | 20.26% |
| 2010-07-02 | 11.25% |
| 2010-04-02 | 9.71% |
| 2009-12-31 | 8.52% |
| 2009-10-02 | 12.77% |
| 2009-07-03 | 11.06% |
| 2009-04-03 | 9.05% |
| 2008-12-31 | 9.62% |
| 2008-09-26 | 11.60% |
| 2008-06-27 | 11.07% |
| 2008-03-28 | 9.13% |
| 2007-12-31 | 10.19% |
| 2007-09-28 | 17.71% |
| 2007-06-29 | 11.65% |
| 2007-03-30 | 9.97% |
| 2006-12-31 | 12.17% |
| 2006-09-29 | 10.97% |
| 2006-06-30 | 13.39% |
| 2006-03-31 | 10.06% |
| 2005-12-31 | 11.12% |
| 2005-09-30 | 11.64% |
| 2005-07-01 | 11.87% |
| 2005-04-01 | 10.31% |
| 2004-12-31 | 11.00% |
| 2004-10-01 | 11.50% |
| 2004-07-02 | 11.24% |
| 2004-04-02 | 9.41% |
| 2003-12-31 | 11.42% |
| 2003-09-26 | 10.59% |
| 2003-06-27 | 9.63% |
| 2003-03-28 | 8.62% |
| 2002-12-31 | 12.68% |
| 2002-09-27 | 10.07% |